Yang et al., 2012 - Google Patents

Recent progress on the liposomes loaded with quantum dots

Yang et al., 2012

View PDF
Document ID
758126281122342312
Author
Yang C
Chen W
Bui B
Xiang G
Publication year
Publication venue
Reviews in Nanoscience and Nanotechnology

External Links

Snippet

Quantum dots (QDs), semiconductor nanocrystals, are recognized as one of the most promising nanostructures for in vitro diagnostic applications. They are considered to be ideal candidates as fluorescent probes for long-term imaging to track whole cells or intracellular …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANO-TECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE OR TREATMENT OF NANO-STRUCTURES
    • B82Y5/00—Nano-biotechnology or nano-medicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Similar Documents

Publication Publication Date Title
Chaturvedi et al. Cancer nanotechnology: a new revolution for cancer diagnosis and therapy
Rafique et al. Recent advances of upconversion nanoparticles in theranostics and bioimaging applications
Tripathi et al. Quantum dots and their potential role in cancer theranostics
Weng et al. Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo
Wang et al. Multifunctional quantum dots and liposome complexes in drug delivery
Al-Jamal et al. Liposome–nanoparticle hybrids for multimodal diagnostic and therapeutic applications
Schroeder et al. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles
Kumar et al. In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer
Zhu et al. Quantum dot-based nanoprobes for in vivo targeted imaging
US20130289520A1 (en) Targeted and light-activated cytosolic drug delivery
Tian et al. Doxorubicin-loaded lipid-quantum dot hybrids: Surface topography and release properties
US20120059240A1 (en) Method for preparation of micellar hybrid nanoparticles for therapeutic and diagnostic applications and compositions thereof
Yan et al. Nanomaterials for drug delivery
JP2008533157A (en) Nanocells for diagnosis and treatment of diseases and disorders
Sigot et al. Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes
Li et al. Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy
Yang et al. Recent progress on the liposomes loaded with quantum dots
Qu et al. Design of multifunctional liposome-quantum dot hybrid nanocarriers and their biomedical application
Nowroozi et al. Theranostic niosomes for direct intratumoral injection: marked enhancement in tumor retention and anticancer efficacy
Faghihi et al. Prospects and challenges of synergistic effect of fluorescent carbon dots, liposomes and nanoliposomes for theragnostic applications
Long et al. The recent patents and highlights of functionally engineered nanoparticles for potential applications in biology, medicine, and nanomedicine
Wu et al. Quantum dots for cancer therapy and bioimaging
Guler et al. BiofuNctionalized nanomaterials for targeting cancer cells
Tian et al. Design and engineering of multifunctional quantum dot-based nanoparticles for simultaneous therapeutic-diagnostic applications
Das et al. Multifunctional liposome-quantum dot hybrid nanocarriers for drug targeting to brain tumors